Preclinical studies on thiocarboxanilide UC-781 as a virucidal agent

Jan Balzarini; Lieve Naesens; Eric Verbeken; Marie Laga; Lut Van Damme; Michael A. Parniak; Lieve Van Mellaert; Jozef Anné; De Clercq Erik

doi:10.1097/00002030-199810000-00004

Abstract

1 min read

The virus that emerged under 0.05% UC-781 remained highly sensitive to the NNRTI, including UC-781, in cell culture, suggesting a lack of resistance development under our experimental conditions.

Related publications

Article2003

Inhibition of Human Immunodeficiency Virus by a New Class of Pyridine Oxide Derivatives

Miguel Stevens, Christophe Pannecouque, De Clercq Erik, Jan Balzarini

Article2021

2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 NNRTIs: Rational Design, Synthesis, Activity Evaluation, and Crystallographic Studies

Dongwei Kang, Francesc X. Ruiz, Yanying Sun, Da Feng, Lanlan Jing, Zhao Wang, Tao Zhang, Shenghua Gao, Lin Sun, De Clercq Erik, Christophe Pannecouque, Eddy Arnold, Peng Zhan, Xinyong Liu

Article2001

Rapid Alternation of Drug Therapy Is Highly Efficient in Suppressing the Emergence of Mutant Drug-Resistant HIV Strains in Cell Culture

Jan Balzarini, De Clercq Erik

Article2019

An E460D Substitution in the NS5 Protein of Tick-Borne Encephalitis Virus Confers Resistance to the Inhibitor Galidesivir (BCX4430) and Also Attenuates the Virus for Mice

Luděk Eyer, Antoine Nougaırède, Marie Uhlířová, Jean‐Sélim Driouich, Darina Zouharová, James J. Valdés, Jan Haviernik, Ernest A. Gould, De Clercq Erik, Xavier de Lamballerie, Daniel Růžek

Preprint2019

An E460D substitution in the NS5 protein of tick-borne encephalitis virus confers resistance to the inhibitor Galidesivir (BCX4430) and also attenuates the virus for mice